According to previous studies CEACAM5 (64), B4GAT1 (65), and AHCY (66) were discovered to be biomarkers of CRC due to their strong involvement in the methylation and inflammatory processes of tumor cells. This evidence concerns the gene CEACAM5 and neoplasm.